Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Johnson and Johnson
Mallinckrodt
Colorcon
Harvard Business School

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Septodont Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SEPTODONT, and when can generic versions of SEPTODONT drugs launch?

SEPTODONT has eight approved drugs.

There are five US patents protecting SEPTODONT drugs.

There are thirty-one patent family members on SEPTODONT drugs in twenty countries.

Summary for Septodont
International Patents:31
US Patents:5
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Septodont

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont OCTOCAINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084048-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Septodont Inc PRILOCAINE HYDROCHLORIDE prilocaine hydrochloride INJECTABLE;INJECTION 079235-001 Sep 29, 2010 RX No Yes   Start Trial   Start Trial
Septodont Inc ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084697-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Septodont Inc ISOCAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 080925-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Baxter
Moodys
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.